Bovo F - Search Results

1

The lower respiratory tract microbiome of critically ill patients with COVID-19.

Gaibani P, Viciani E, Bartoletti M, Lewis RE, Tonetti T, Lombardo D, Castagnetti A, Bovo F, Horna CS, Ranieri M, Viale P, Re MC, Ambretti S. Gaibani P, et al. Among authors: bovo f. Sci Rep. 2021 May 12;11(1):10103. doi: 10.1038/s41598-021-89516-6. Sci Rep. 2021. PMID: 33980943 Free PMC article.

2

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study.

Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, Ambretti S, Pensalfine G, Appolloni L, Bartoletti M, Tedeschi S, Tumietto F, Lewis R, Viale P, Giannella M. Pascale R, et al. Among authors: bovo f. Infect Control Hosp Epidemiol. 2022 Apr;43(4):461-466. doi: 10.1017/ice.2021.144. Epub 2021 Apr 16. Infect Control Hosp Epidemiol. 2022. PMID: 33858547 Free PMC article.

3

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018.

Gaibani P, Lombardo D, Bussini L, Bovo F, Munari B, Giannella M, Bartoletti M, Viale P, Lazzarotto T, Ambretti S. Gaibani P, et al. Among authors: bovo f. Antibiotics (Basel). 2021 May 6;10(5):536. doi: 10.3390/antibiotics10050536. Antibiotics (Basel). 2021. PMID: 34066420 Free PMC article.

4

Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.

Gaibani P, Bovo F, Bussini L, Lazzarotto T, Amadesi S, Bartoletti M, Viale P, Ambretti S. Gaibani P, et al. Among authors: bovo f. J Antimicrob Chemother. 2022 May 29;77(6):1570-1577. doi: 10.1093/jac/dkac100. J Antimicrob Chemother. 2022. PMID: 35373297

5

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient.

Gaibani P, Bussini L, Amadesi S, Bartoletti M, Bovo F, Lazzarotto T, Viale P, Ambretti S. Gaibani P, et al. Among authors: bovo f. Microorganisms. 2022 Apr 5;10(4):778. doi: 10.3390/microorganisms10040778. Microorganisms. 2022. PMID: 35456827 Free PMC article.

6

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.

Gaibani P, Giani T, Bovo F, Lombardo D, Amadesi S, Lazzarotto T, Coppi M, Rossolini GM, Ambretti S. Gaibani P, et al. Among authors: bovo f. Antibiotics (Basel). 2022 May 6;11(5):628. doi: 10.3390/antibiotics11050628. Antibiotics (Basel). 2022. PMID: 35625273 Free PMC article. Review.

7

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020.

Bovo F, Lombardo D, Lazzarotto T, Ambretti S, Gaibani P. Bovo F, et al. Antibiotics (Basel). 2022 Nov 14;11(11):1621. doi: 10.3390/antibiotics11111621. Antibiotics (Basel). 2022. PMID: 36421265 Free PMC article.

8

Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients.

Gaibani P, Bovo F, Bussini L, Bartoletti M, Lazzarotto T, Viale P, Pea F, Ambretti S. Gaibani P, et al. Among authors: bovo f. Clin Microbiol Infect. 2023 May;29(5):654.e1-654.e4. doi: 10.1016/j.cmi.2023.01.012. Epub 2023 Jan 27. Clin Microbiol Infect. 2023. PMID: 36716999 Free article.

9

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae.

Bovo F, Lazzarotto T, Ambretti S, Gaibani P. Bovo F, et al. Antibiotics (Basel). 2023 Mar 20;12(3):614. doi: 10.3390/antibiotics12030614. Antibiotics (Basel). 2023. PMID: 36978482 Free PMC article.

10

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria.

Palombo M, Bovo F, Amadesi S, Gaibani P. Palombo M, et al. Among authors: bovo f. Antibiotics (Basel). 2023 May 5;12(5):858. doi: 10.3390/antibiotics12050858. Antibiotics (Basel). 2023. PMID: 37237761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters